Atopic dermatitis affects an estimated 15% of children who experience persistent difficulty controlling pruritus or itch with associated scratching, further skin barrier damage, secondary skin ...

A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

The following is a summary of “Skin Microbiome in the First Year of Life and Its Association With Atopic Dermatitis,” ...

Atopic dermatitis (AD) remains a persistent challenge for pediatric patients, often beginning in infancy and continuing into childhood. “Somewhere between 7, 8, 10% of kids will have episodic and some ...

For the study, investigators evaluated children aged 6 months to 5 years with moderate-to-severe atopic dermatitis who had been treated with either dupilumab or a placebo. Researchers compared ...

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

"Many children suffer from multiple allergic conditions at the same time, so knowing that dupilumab can be used to safely and effectively treat their atopic dermatitis whether or not they have ...

Annual Meeting took place in Toronto, Canada, July 11-15, with our top coverage including the hot topics of combating ...

Educational interventions for patients, including both in-person and online methods, significantly reduced atopic dermatitis (AD) severity.

The FDA approved Vtama (tapinarof) cream 1% for treating atopic dermatitis (AD) in adults and children as young as ...